Immediate Impact
2 standout
Citing Papers
CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024
2024 Standout
Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design
2024 Standout
Works of Victor Omollo being referenced
Doxycycline Prophylaxis to Prevent Sexually Transmitted Infections in Women
2023
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Victor Omollo | 227 | 146 | 128 | 23 | 285 | |
| Massimo Ghidinelli | 235 | 164 | 91 | 23 | 328 | |
| George Githuka | 191 | 157 | 72 | 19 | 286 | |
| Marie-Marcelle Deschamps | 242 | 131 | 123 | 16 | 324 | |
| Laura Gibney | 164 | 158 | 155 | 12 | 306 | |
| Paulin Fao | 168 | 104 | 134 | 18 | 214 | |
| Nadia Ahmed | 198 | 111 | 113 | 37 | 323 | |
| Annette E Ghee | 135 | 131 | 125 | 17 | 333 | |
| Thomas Agyarko‐Poku | 230 | 210 | 136 | 25 | 333 | |
| KA Fenton | 105 | 76 | 105 | 20 | 206 | |
| K E Bharucha | 235 | 162 | 113 | 14 | 301 |
All Works
Login with ORCID to disown or claim papers
Loading papers...